Analysis of dysarthria in a 55-year-old female patient with multiple sclerosis by means of an IT tool based on respiratory and phonatory examination – a case study

Authors

  • Wojciech A. Warmbier Clinic of Neurology with the Stroke Unit, Clinical Hospital No. 2 in Rzeszow, Rzeszow, Poland; Subcarpathian Center for Neurorehabilitation, Rzeszow, Poland https://orcid.org/0009-0007-3339-8421
  • Małgorzata Popiel Clinic of Neurology with the Stroke Unit, Clinical Hospital No. 2 in Rzeszow, Rzeszow, Poland https://orcid.org/0000-0002-9110-8599
  • Agnieszka Guzik Department of Physiotherapy, Institute of Health Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland https://orcid.org/0000-0002-4582-4383
  • Mariusz Drużbicki Department of Physiotherapy, Institute of Health Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland https://orcid.org/0000-0003-4511-8419
  • Halina Bartosik-Psujek Clinic of Neurology with the Stroke Unit, Clinical Hospital No. 2 in Rzeszow, Rzeszow, Poland; Department of Neurology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland https://orcid.org/0000-0002-2860-6456

DOI:

https://doi.org/10.15584/ejcem.2023.3.29

Keywords:

dysarthria, multiple sclerosis, respiratory and phonatory disorders

Abstract

Introduction and aim. There are no available objective tools for assessing dysarthric disorders in the course of multiple sclerosis (MS). The aim of the study is to analyse a case of mixed dysarthria in a 55-year-old female patient in the course of secondary progressive MS and to present the severity of the patient’s dysarthric disorder in contrast with the control group as evaluated by means of an IT tool based on respiratory and phonatory examination.

Description of the case. A 55-year-old patient was admitted to the Clinic of Neurology with the Stroke Unit due to a worsening condition in the course of MS. She was examined with an objective tool for respiratory and phonatory disorders. Her results were, then, compared to those of 24 healthy individuals from the control group, matched in terms of sex and age. Following speech parameters were analysed: phonetics of utterances, number of produced syllables per breath during the execution of individual texts, sound quality, intonation, and the total performance time of each.

Conclusion. The analysed case indicates that the developed objective IT tool is a promising diagnostic method that can facilitate diagnosis and can be used in clinical practice.

Supporting Agencies

This research received external funding. The IT tool created in the course of the project run by BD Center Ltd.: Innovative IT tool aiding diagnostic process, prognosis and tracking of change dynamics in neurological patients – development work and its implementation’ No RPPK.01.02.00-18-0004/20 co-financed by the European Regional Development Fund carried out within Regional Operational Programme of Podkarpackie Voivodeship 2014-2020 – Priority Axis 1: Competitive and Innovative Economy.

Downloads

Download data is not yet available.

References

Browne P, Chandraratna D, Angood C, et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014;9;83(11):1022-1024. doi: 10.1212/WNL.0000000000000768

Morawska J, Niebudek-Bogusz E, Stasiołek M, Świderek-Matysiak M, Pietruszewska W. Speech Pathology-Specific Questionnaire for Persons with Multiple Sclerosis (SMS): adaptation, validation and preliminary assessment of the diagnostic potential. Mult Scler Relat Disord. 2021;49:102796. doi: 10.1016/j.msard.2021.102796

Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019;5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035

Filippi M, Danesi R, Derfuss T, et al. Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis. J Neurol. 2022;269(3):1670-1677. doi: 10.1007/s00415-021-10836-8

De Biagi F, Heikkola LM, Nordio S, Ruhaak L. Update on Recent Developments in Communication and Swallowing in Multiple Sclerosis. Int J MS Care. 2020;22(6):270-275. doi: 10.7224/1537-2073.2020-023

Kappos L, Wolinsky JS, Giovannoni G, et al. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. JAMA Neurol. 2020;1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568

Fazeli M, Moradi N, Soltani M, et al. Dysphonia Characteristics and Vowel Impairment in Relation to Neurological Status in Patients with Multiple Sclerosis. J Voice. 2020;34(3):364-370. doi: 10.1016/j.jvoice.2018.09.018

Merson RM, Rolnick MI. Speech-language pathology and dysphagia in multiple sclerosis. Phys Med Rehabil Clin N Am. 1998;9(3):631-641.

Chiara T, Martin D, Sapienza C. Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis. Neurorehabil Neural Repair. 2007;21(3):239-249. doi: 10.1177/1545968306294737

El-Wahsh S, Heard R, Bogaardt H, Kumfor F, Ballard KJ. Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis. Int J MS Care. 2021;23(2):85-92. doi: 10.7224/1537-2073.2020-096

De Pauw A, Dejaeger E, D'hooghe B, Carton H. Dysphagia in multiple sclerosis. Clin Neurol Neurosurg. 2002;104(4):345-351. doi: 10.1016/s0303-8467(02)00053-7

Fischer MT, Wimmer I, Höftberger R, Gerlach S, et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain. 2013;136(Pt6):1799-17815. doi: 10.1093/brain/awt110

Guzy A. Voice emission diagnosis using a structured interview: practical implications. Logopaedica Lodziensia, 2019;(3):79-91. doi: 10.18778/2544-7238.03.06

Rusz, J, Benova, B, Ruzickova, H, et al. Characteristics of motor speech phenotypes in multiple sclerosis. Mult Scler Relat Disord. 2018;19:62-69. doi: 10.1016/j.msard.2017.11.007

Rodgers JD, Tjaden, K, Feenaughty L, Weinstock-Guttman B, Benedict RH. Influence of cognitive function on speech and articulation rate in multiple sclerosis. J Int Neuropsychol Soc. 2013;19:173-180. doi: 10.1017/S1355617712001166

Hartelius L, Theodoros D, Cahill L, Lillvik M. Comparability of perceptual analysis of speech characteristics in Australian and Swedish speakers with multiple sclerosis. Folia Phoniatr Logop. 2003;55(4):177-188. doi: 10.1159/000071017

Sechidis K, Fusaroli R, Orozco-Arroyave JR, Wolf D, Zhang YP. A machine learning perspective on the emotional content of Parkinsonian speech. Artif Intell Med. 2021;115:102061. doi: 10.1016/j.artmed.2021.102061

Downloads

Published

2023-09-30

How to Cite

Warmbier, W. A., Popiel, M., Guzik, A., Drużbicki, M., & Bartosik-Psujek, H. (2023). Analysis of dysarthria in a 55-year-old female patient with multiple sclerosis by means of an IT tool based on respiratory and phonatory examination – a case study. European Journal of Clinical and Experimental Medicine, 21(3), 648–653. https://doi.org/10.15584/ejcem.2023.3.29

Issue

Vol. 21 No. 3 (2023)

Section

CASUISTIC PAPERS

License

Copyright (c) 2023 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.